Local Treatment of Non-small Cell Lung Cancer with a Spray-Dried Bevacizumab Formulation.

Authors:
Shepard KB; Vodak DT; Kuehl PJ; Revelli D; Zhou Y and 7 more

Journal:
AAPS PharmSciTech

Publication Year: 2021

DOI:
10.1208/s12249-021-02095-7

PMCID:
PMC8408070

PMID:
34467438

View on PubMed View on PMC View Publisher
Journal Information

Full Title: AAPS PharmSciTech

Abbreviation: AAPS PharmSciTech

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
3D Printing as a Technological Strategy for the Personalized Treatment of Wound Healing.
Uchida DT; Bruschi ML. (2023) - Transparency Score: 3/6
Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strat…
Chan HW; Chow S; Zhang X and 3 more (2023) - Transparency Score: 3/6
3D Bioprinting of Human Hollow Organs.
Panja N; Maji S; Choudhuri S and 2 more (2022) - Transparency Score: 2/6
3D Printing: Applications in Tissue Engineering, Medical Devices, and Drug Delivery.
Pavan Kalyan BG; Kumar L. (2022) - Transparency Score: 3/6
A Comprehensive Investigation Regarding the Differentiation of the Procurable COVID-19 Vaccines.
Banerjee S; Banerjee D; Singh A and 1 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of InterestThe authors declare no competing interests. Conflict of Interest The authors declare no competing interests."

Evidence found in paper:

"Funding This study was funded in its entirety by Lonza."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025